세계의 에피제네틱스 시장 규모 조사 및 예측 : 제품별, 용도별, 기술별, 지역별 분석(2023-2030년)

Global Epigenetics Market is anticipated to grow with a healthy growth rate of more than 16.1% over the forecast period 2023-2030. Epigenetics is the study of gene changes that may affect common gene mutations. Epigenetic mechanisms are being linked to an increasing number of chronic diseases and disorders, including cardiovascular diseases, autoimmune diseases, and neurodegenerative disorders, in addition to environmental factors and nutrition, which affect epigenetic processes such as DNA methylation, histone modification, and non-coding RNA. Innovative therapeutic strategies can now be developed because of the identification of numerous cutting-edge therapeutic targets through epigenetic research. Factors such as rising expenditure in Research and Development, Increasing Cancer cases and increasing uses of non-oncological applications of epigenetics are expected to drive the growth of the epigenetics market in the forecast year 2023-2030.

According to Statista, cancer is one of the biggest health issues in the world that affects millions of people of all ages and genders and has a significant negative influence on quality of life. The incidence of new cancer cases is rising along with the average age of the world's population, which results in more deaths each year. Globally, there were around 10 million cancer-related deaths in 2020; and this number is predicted to rise to over 16 million, by 2040. Rising healthcare research & development expenditure globally is also anticipated to fuel market expansion. According to the World Health Organization in December 2021, the gross domestic research and development expenditure (health GERD) as a percentage of gross domestic product (GDP) in high-income nations was 0.21% and 0.02% for upper middle- and low-income nations. Moreover, the increasing demand in patients' base for personalized medicine and high use of epigenetics in therapeutics and drug development may create lucrative opportunities for the market in the forecast period. However, the lack of skilled professionals working in this field stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Epigenetics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the presence of key market players, significant investments in research and development, and a rise in cancer cases. According to the United States National Institute of Health, USD 1,098 million had been allocated for cancer genomics research as of December 2021, thus driving the growth of the market. However, Asia Pacific is expected to be the fastest growing region during the forecast period, owing to rising awareness in epigenetics, prevalence of key players in developing countries of Asia Pacific, and developing infrastructure for research and clinical settings.

Major market player included in this report are:

• Abcam PLC
• Illumina Inc.
• Bio-Rad Technologies
• Hologic Inc (Diagenode Inc.)
• Thermo Fisher Scientific
• Perkin Elmer
• New England Biolabs
• Active Motiff
• Zymo Research Corporation
• Qiagen NV

Recent Developments in the Market:

• In December 2022, Merck Announces Mersana Therapeutics Collaboration to Create New Immunostimulatory Antibody-Drug Conjugates.
• In August 2022, Merck KGaA, a leading science and technology company, signed a definitive agreement to acquire the chemical division of Mecaro Co. Ltd. (Mecaro), a publicly traded Korean manufacturer of heater blocks and chemical precursors for semiconductors.
• In February 2022, Element Biosciences, Inc., the creator of a novel and innovative DNA sequencing technology partnered with Dovetail Genomics to showcase the benefits and effectiveness of Dovetail's proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element's AVITI System.

Global Epigenetics Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Application, Technology, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Instruments
• Kits and Reagents
• Others

By Application:

• Oncology
• Autoimmune Diseases
• Metabolic Diseases
• CNS/Pain Diseases
• Cardiovascular Diseases

By Technology:

• Methylation
• Acetylation
• Phosphorylation
• Other Technologies

By Region:

• North America
• U.S.
• Canada

• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

• Latin America
• Brazil
• Mexico

• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Epigenetics Market, by region, 2020-2030 (USD Billion)
  • 1.2.2. Epigenetics Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Epigenetics Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Epigenetics Market, by Technology, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Technology
• 1.5. Research Assumption

Chapter 2. Global Epigenetics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Epigenetics Market Dynamics

• 3.1. Epigenetics Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising funding in Research and Development
    • 3.1.1.2. Increasing Cancer cases
    • 3.1.1.3. Increasing uses of non-oncological applications of epigenetics
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of skilled professionals
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising demand of patients for personalized medicine
    • 3.1.3.2. High use in therapeutics and drug development

Chapter 4. Global Epigenetics Market: Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economic
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Epigenetics Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Epigenetics Market by Product, Performance - Potential Analysis
• 5.3. Global Epigenetics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Epigenetics Market, Sub Segment Analysis
  • 5.4.1. Instruments
  • 5.4.2. Kits and Reagents
  • 5.4.3. Others

Chapter 6. Global Epigenetics Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Epigenetics Market by Application, Performance - Potential Analysis
• 6.3. Global Epigenetics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Epigenetics Market, Sub Segment Analysis
  • 6.4.1. Oncology
  • 6.4.2. Autoimmune Diseases
  • 6.4.3. Metabolic Diseases
  • 6.4.4. CNS/Pain Diseases
  • 6.4.5. Cardiovascular Diseases

Chapter 7. Global Epigenetics Market, by Technology

• 7.1. Market Snapshot
• 7.2. Global Epigenetics Market by Technology, Performance - Potential Analysis
• 7.3. Global Epigenetics Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 7.4. Epigenetics Market, Sub Segment Analysis
  • 7.4.1. Methylation
  • 7.4.2. Acetylation
  • 7.4.3. Phosphorylation
  • 7.4.4. Other Technologies

Chapter 8. Global Epigenetics Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Epigenetics Market, Regional Market Snapshot
• 8.4. North America Epigenetics Market
  • 8.4.1. U.S. Epigenetics Market
    • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Epigenetics Market
• 8.5. Europe Epigenetics Market Snapshot
  • 8.5.1. U.K. Epigenetics Market
  • 8.5.2. Germany Epigenetics Market
  • 8.5.3. France Epigenetics Market
  • 8.5.4. Spain Epigenetics Market
  • 8.5.5. Italy Epigenetics Market
  • 8.5.6. Rest of Europe Epigenetics Market
• 8.6. Asia-Pacific Epigenetics Market Snapshot
  • 8.6.1. China Epigenetics Market
  • 8.6.2. India Epigenetics Market
  • 8.6.3. Japan Epigenetics Market
  • 8.6.4. Australia Epigenetics Market
  • 8.6.5. South Korea Epigenetics Market
  • 8.6.6. Rest of Asia Pacific Epigenetics Market
• 8.7. Latin America Epigenetics Market Snapshot
  • 8.7.1. Brazil Epigenetics Market
  • 8.7.2. Mexico Epigenetics Market
• 8.8. Middle East & Africa Epigenetics Market
  • 8.8.1. Saudi Arabia Epigenetics Market
  • 8.8.2. South Africa Epigenetics Market
  • 8.8.3. Rest of Middle East & Africa Epigenetics Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Abcam PLC
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Illumina Inc.
  • 9.3.3. Bio-Rad Technologies
  • 9.3.4. Hologic Inc (Diagenode Inc.)
  • 9.3.5. Thermo Fisher Scientific
  • 9.3.6. Perkin Elmer
  • 9.3.7. New England Biolabs
  • 9.3.8. Active Motiff
  • 9.3.9. Zymo Research Corporation
  • 9.3.10. Qiagen NV

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption